112 related articles for article (PubMed ID: 12195960)
1. Fungal metabolites, asterric acid derivatives inhibit vascular endothelial growth factor (VEGF)-induced tube formation of HUVECs.
Lee HJ; Lee JH; Hwang BY; Kim HS; Lee JJ
J Antibiot (Tokyo); 2002 Jun; 55(6):552-6. PubMed ID: 12195960
[TBL] [Abstract][Full Text] [Related]
2. gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor.
Basaki Y; Chikahisa L; Aoyagi K; Miyadera K; Yonekura K; Hashimoto A; Okabe S; Wierzba K; Yamada Y
Angiogenesis; 2001; 4(3):163-73. PubMed ID: 11911014
[TBL] [Abstract][Full Text] [Related]
3. Epoxyquinol B, a fungal metabolite with a potent antiangiogenic activity.
Kakeya H; Onose R; Yoshida A; Koshino H; Osada H
J Antibiot (Tokyo); 2002 Sep; 55(9):829-31. PubMed ID: 12458775
[No Abstract] [Full Text] [Related]
4. Anti-angiogenic activities of gliotoxin and its methylthioderivative, fungal metabolites.
Lee HJ; Lee JH; Hwang BY; Kim HS; Lee JJ
Arch Pharm Res; 2001 Oct; 24(5):397-401. PubMed ID: 11693538
[TBL] [Abstract][Full Text] [Related]
5. Bioactive asterric acid derivatives from the Antarctic ascomycete fungus Geomyces sp.
Li Y; Sun B; Liu S; Jiang L; Liu X; Zhang H; Che Y
J Nat Prod; 2008 Sep; 71(9):1643-6. PubMed ID: 18720971
[TBL] [Abstract][Full Text] [Related]
6. New chlorinated diphenyl ethers from an Aspergillus species.
Hargreaves J; Park JO; Ghisalberti EL; Sivasithamparam K; Skelton BW; White AH
J Nat Prod; 2002 Jan; 65(1):7-10. PubMed ID: 11809055
[TBL] [Abstract][Full Text] [Related]
7. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
Wood JM
Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
[TBL] [Abstract][Full Text] [Related]
9. Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668.
Zhang H; Issekutz AC
Am J Pathol; 2002 Jun; 160(6):2219-30. PubMed ID: 12057924
[TBL] [Abstract][Full Text] [Related]
10. Topotecan inhibits VEGF- and bFGF-induced vascular endothelial cell migration via downregulation of the PI3K-Akt signaling pathway.
Nakashio A; Fujita N; Tsuruo T
Int J Cancer; 2002 Mar; 98(1):36-41. PubMed ID: 11857382
[TBL] [Abstract][Full Text] [Related]
11. ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase.
Hirata A; Ogawa S; Kometani T; Kuwano T; Naito S; Kuwano M; Ono M
Cancer Res; 2002 May; 62(9):2554-60. PubMed ID: 11980649
[TBL] [Abstract][Full Text] [Related]
12. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
[TBL] [Abstract][Full Text] [Related]
13. A novel dihydroxanthenone, AGI-B4 with inhibition of VEGF-induced endothelial cell growth.
Kim HS; Park IY; Park YJ; Lee JH; Hong YS; Lee JJ
J Antibiot (Tokyo); 2002 Jul; 55(7):669-72. PubMed ID: 12243460
[No Abstract] [Full Text] [Related]
14. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.
Bussolati B; Dunk C; Grohman M; Kontos CD; Mason J; Ahmed A
Am J Pathol; 2001 Sep; 159(3):993-1008. PubMed ID: 11549592
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling.
Deroanne CF; Bonjean K; Servotte S; Devy L; Colige A; Clausse N; Blacher S; Verdin E; Foidart JM; Nusgens BV; Castronovo V
Oncogene; 2002 Jan; 21(3):427-36. PubMed ID: 11821955
[TBL] [Abstract][Full Text] [Related]
16. A small peptide derived from Flt-1 (VEGFR-1) functions as an angiogenic inhibitor.
Tan DC; Kini RM; Jois SD; Lim DK; Xin L; Ge R
FEBS Lett; 2001 Apr; 494(3):150-6. PubMed ID: 11311231
[TBL] [Abstract][Full Text] [Related]
17. Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin.
Urbich C; Reissner A; Chavakis E; Dernbach E; Haendeler J; Fleming I; Zeiher AM; Kaszkin M; Dimmeler S
FASEB J; 2002 May; 16(7):706-8. PubMed ID: 11978735
[TBL] [Abstract][Full Text] [Related]
18. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
[TBL] [Abstract][Full Text] [Related]
19. Effect of tecogalan sodium on angiogenesis in vitro by choroidal endothelial cells.
Sakamoto T; Ishibashi T; Kimura H; Yoshikawa H; Spee C; Harris MS; Hinton DR; Ryan SJ
Invest Ophthalmol Vis Sci; 1995 May; 36(6):1076-83. PubMed ID: 7537258
[TBL] [Abstract][Full Text] [Related]
20. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.
Park HJ; Kong D; Iruela-Arispe L; Begley U; Tang D; Galper JB
Circ Res; 2002 Jul; 91(2):143-50. PubMed ID: 12142347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
